Qingdao Baheal Valuation
| 301015 Stock | 27.53 0.20 0.73% |
At this time, the company appears to be overvalued. Qingdao Baheal Medical holds a recent Real Value of USD22.51 per share. The prevailing price of the company is USD27.53. Our model determines the value of Qingdao Baheal Medical from analyzing the company fundamentals such as Return On Equity of 0.31, operating margin of 0.18 %, and Shares Outstanding of 525.61 M as well as examining its technical indicators and probability of bankruptcy.
Price Book 6.2654 | Enterprise Value 15.2 B | Enterprise Value Ebitda 13.9726 | Price Sales 1.8144 | Trailing PE 19.9493 |
Overvalued
Today
Please note that Qingdao Baheal's price fluctuation is somewhat reliable at this time. Calculation of the real value of Qingdao Baheal Medical is based on 3 months time horizon. Increasing Qingdao Baheal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Qingdao Baheal is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Qingdao Stock. However, Qingdao Baheal's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.53 | Real 22.51 | Hype 27.13 | Naive 26.54 |
The real value of Qingdao Stock, also known as its intrinsic value, is the underlying worth of Qingdao Baheal Medical Company, which is reflected in its stock price. It is based on Qingdao Baheal's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Qingdao Baheal's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Qingdao Baheal Medical helps investors to forecast how Qingdao stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Qingdao Baheal more accurately as focusing exclusively on Qingdao Baheal's fundamentals will not take into account other important factors: Qingdao Baheal Cash |
|
Qingdao Baheal Total Value Analysis
Qingdao Baheal Medical is presently estimated to have takeover price of 15.24 B with market capitalization of 14.47 B, debt of 461.89 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Qingdao Baheal fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.24 B | 14.47 B | 461.89 M |
Qingdao Baheal Investor Information
About 78.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 29th of May 2024. Qingdao Baheal Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 676.5 M | 938.2 M |
|
|
Qingdao Baheal Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Qingdao Baheal has an asset utilization ratio of 142.75 percent. This suggests that the Company is making USD1.43 for each dollar of assets. An increasing asset utilization means that Qingdao Baheal Medical is more efficient with each dollar of assets it utilizes for everyday operations.Qingdao Baheal Ownership Allocation
Qingdao Baheal owns a total of 525.61 Million outstanding shares. Qingdao Baheal holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.6 pct. of Qingdao Baheal Medical outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Qingdao Baheal Profitability Analysis
The company reported the revenue of 7.56 B. Net Income was 656.31 M with profit before overhead, payroll, taxes, and interest of 2.08 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Qingdao Baheal's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Qingdao Baheal and how it compares across the competition.
About Qingdao Baheal Valuation
The stock valuation mechanism determines Qingdao Baheal's current worth on a weekly basis. Our valuation model uses a comparative analysis of Qingdao Baheal. We calculate exposure to Qingdao Baheal's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Qingdao Baheal's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.3 B | 2 B |
Qingdao Baheal Quarterly Retained Earnings |
|
Complementary Tools for Qingdao Stock analysis
When running Qingdao Baheal's price analysis, check to measure Qingdao Baheal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Baheal is operating at the current time. Most of Qingdao Baheal's value examination focuses on studying past and present price action to predict the probability of Qingdao Baheal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Baheal's price. Additionally, you may evaluate how the addition of Qingdao Baheal to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |